Key Sessions
Louis Boon, PhD
KEYNOTE: Biomarker, FIRST! IgA and its Receptor CD89
JJP Biologics
Steffen Goletz, PhD
KEYNOTE: Engineering the Next Generation of Antibody Therapeutics: Insights from Big Data and Novel Platforms
Danish Technical University
Jenny Ann Prange
Helping patients to regain control: From pre-clinical research to clinical
MUVON Therapeutics AG